Summary
Updated Aug 31, 2026
Stephen A. Hurly is Chief Executive Officer of LAVA Therapeutics NV (LVTX). 1 SEC Form 4 filing on record, dated 17 November 2025.
Recent Transactions
1Every recent SEC Form 4 transaction Stephen A. Hurly has reported, most recent first.
Trading Pattern
InsiderAlpha's records for Stephen A. Hurly go back to 2025: 1 primary Form 4 filing, an average of 0.5 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Stephen A. Hurly files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Versant Venture Capital VI, L.P. - $6.57M of LVTX open-market activity in the last 12 months
- Gilde Healthcare Iv U.A. Cooperatieve - $5.14M of LVTX open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Stephen A. Hurly?
Stephen A. Hurly is a corporate insider, tracked as Chief Executive Officer of LAVA Therapeutics NV (LVTX). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Stephen A. Hurly last file a Form 4?
The only primary Form 4 on record is dated 17 November 2025.
Where can I see all of Stephen A. Hurly's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Stephen A. Hurly and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial